STERIS USA Competitors and Similar CompaniesClear all

STERIS USA's competitors and similar companies include ZimVie, Smith & Nephew, Terumo Medical and Shenzhen YHLO Biotech.

	STERIS USA STERIS USA is a company that provides infection prevention and other procedural products, focused primarily on the healthcare, pharmaceutical, and research markets.	ZimVie ZimVie is a company that produces dental, spine, and bone healing products.	Smith & Nephew Smith & Nephew is a medical technology company.	Terumo Medical Terumo Medical is a company that develops medical devices.	Shenzhen YHLO Biotech Shenzhen YHLO Biotech (深圳市亚辉龙生物科技股份有限公司) is a company that develops, produces, and sells in vitro diagnostic instruments.
Founding Date	Founding Date 1985	Founding Date 2022	Founding Date 1856	Founding Date 1972	Founding Date 2008
Type	Type Subsidiary	Type Public	Type Public	Type Subsidiary	Type Public
Tags	Tags Healthcare medical devices medtech	Tags Healthcare medical devices medtech	Tags Healthcare healthtech medical devices medtech	Tags Healthcare medical devices medtech	Tags Healthcare medical devices medtech
Locations	Locations Mentor, US HQ	Locations Westminster, US HQ Macquarie Park, AU Wien, AT Mechelen, BE Sao Paulo, BR Mississauga, CA Santiago, CL see more	Locations Watford, GB HQ Buenos Aires, AR Macquarie Park, AU Schwechat, AT Zaventem, BE São Paolo, BR Mississauga, CA see more	Locations Somerset, US HQ Sao Paulo, BR Vaughan, CA Hangzhou, CN Ciudad De México, MX Breinigsville, US Elkton, US see more	Locations Shen Zhen Shi, CN HQ
Employees	Employees 7,655	Employees 2,700	Employees 19,081	Employees 2,639	Employees 1,7761% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 441.1 m	Valuation ($) 13.4 b	Valuation ($) N/A	Valuation ($) 1.9 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $457.4m (FY, 2023)	Revenue (est.) $5.5b (FY, 2023)	Revenue (est.) N/A	Revenue (est.) ¥2b (FY, 2023)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $1b (FY, 2023)	Cost of goods N/A	Cost of goods ¥886.8m (FY, 2023)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $4.5b (FY, 2023)	Gross profit N/A	Gross profit ¥1.2b (FY, 2023)
Net income	Net income N/A	Net income ($393.3m) (FY, 2023)	Net income $263m (FY, 2023)	Net income N/A	Net income ¥279.2m (FY, 2023)